66.18MMarket Cap0.77P/E (TTM)
8.150High7.550Low34.62KVolume7.550Open8.130Pre Close265.74KTurnover0.80%Turnover RatioLossP/E (Static)8.73MShares27.75952wk High0.78P/B32.90MFloat Cap2.29952wk Low--Dividend TTM4.34MShs Float108.395Historical High--Div YieldTTM7.38%Amplitude2.299Historical Low7.675Avg Price1Lot Size
Scienture Holdings Stock Forum
3 MINUTES AGO, 8:05 AM EST
VIA GLOBENEWSWIRE
Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 2041
Tuesday, 10th December at 8:05 am
COMMACK, NY and TAMPA, FL, Dec. 10, 2024 (GLOBE NEWSWIRE) -- SCIENTURE, LLC ("the "Company"), a wholly owned subsidiary of SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), focused on developing and commercializing novel brande...
There would be no stopping this with the right volume ...
💸💸💸💸💸
Scienture Holdings, Inc. Announces Private Placement of $3 Million of 10% Secured Convertible Debentures as Initial Tranche of $12 Million Offering and Entry into $50 Million Equity Line of Credit Agreement
Scienture Holdings to Receive Funding of Up to $12 Million From Private Placement of 10% Secured Convertible Debentures and Up to $50 Million from Equity Line of Credit
Tampa, FL, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Scienture Holdings, Inc. (NASDAQ:SCNX) (the "...
Ask Volume =🚀
🤫🤟✌️
No comment yet